HGH HoldingsSGX:5GZ Cash-to-Debt is 0.40 as of Dec. 2025, which is 61% below its 10-year median of 1.03. The stock has 2 warning signs investors should review. Among 3,057 Industrial Products companies, HGH Holdings ranks worse than 72.36% on this metric.
Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. HGH Holdings's cash to debt ratio for the quarter that ended in Dec. 2025 was 0.40.
If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, HGH Holdingscouldn't pay off its debt using the cash in hand for the quarter that ended in Dec. 2025.
The historical rank and industry rank for HGH Holdings's Cash-to-Debt or its related term are showing as below:
SGX:5GZ'
s Cash-to-Debt Range Over the Past 10 Years
Min: 0.2 Med: 1.03 Max: 1.53
Current: 0.4
During the past 13 years, HGH Holdings's highest Cash to Debt Ratio was 1.53. The lowest was 0.20. And the median was 1.03.
SGX:5GZ's Cash-to-Debt is ranked worse than 72.36% of 3057
companies
in the Industrial Products industry
Industry Median: 1.18
vs SGX:5GZ: 0.40
HGH Holdings (SGX:5GZ) Cash-to-Debt Explanation
If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.
HGH Holdings Cash-to-Debt Related Terms
HGH Holdings Cash-to-Debt Historical Data
* Premium members only.
The historical data trend for HGH Holdings's Cash-to-Debt can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
For the Electrical Equipment & Parts subindustry, HGH Holdings's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
HGH Holdings Cash-to-Debt vs Industrial Products Industry
For the Industrial Products industry and Industrials sector, HGH Holdings's Cash-to-Debt distribution charts can be found below:
* The bar in red indicates where HGH Holdings's Cash-to-Debt falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HGH Holdings (SGX:5GZ) has a Cash-to-Debt of 0.40 as of Dec. 2025. This is 61% below median its historical median of 1.03. Over the past decade, HGH Holdings' Cash-to-Debt has ranged from 0.20 to 1.53. According to the industry distribution chart, HGH Holdings ranks #2212 out of 3057 companies in the Industrial Products industry, placing it in the top 72.4%.
Is HGH Holdings' Cash-to-Debt too high?
HGH Holdings' current Cash-to-Debt of 0.40 is 61% below median its 10-year median of 1.03. Over the past 10 years, this metric has ranged from a low of 0.20 to a high of 1.53. The Industrial Products industry median Cash-to-Debt is 1.18. HGH Holdings' value of 0.40 is 66.1% below this industry median. Based on the distribution chart, HGH Holdings ranks #2212 out of 3057 companies in the Industrial Products industry, which is below the industry midpoint.
How does HGH Holdings' Cash-to-Debt compare to VRT and BE?
According to the Industrial Products industry distribution chart, HGH Holdings ranks #2212 out of 3057 companies for Cash-to-Debt. This places HGH Holdings in the lower half of its industry. The industry median Cash-to-Debt is 1.18. HGH Holdings' value of 0.40 is 66.1% below this benchmark. Historically, HGH Holdings' own Cash-to-Debt has ranged from 0.20 to 1.53 over the past decade. While the company's 10-year median is 1.03 vs. the industry median of 1.18, HGH Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash-to-Debt for an Industrial Products company?
The median Cash-to-Debt among Industrial Products companies is 1.18, based on 3,057 companies in the industry. Companies in the top quartile (top 25%) have a Cash-to-Debt significantly above this median, while those in the bottom quartile fall well below. However, Cash-to-Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. HGH Holdings's current Cash-to-Debt of 0.40 is 66.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash-to-Debt mean?
A high Cash-to-Debt can signal that a stock is expensive relative to its fundamentals. For the Industrial Products industry, the median Cash-to-Debt is 1.18 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. HGH Holdings's current Cash-to-Debt is 0.40, which is 61% below median its own 10-year median of 1.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HGH Holdings stock overvalued right now?
Based on GuruFocus' analysis, HGH Holdings (SGX:5GZ) is currently considered Possible Value Trap. The stock's GF Value™ is S$0.04, compared to a current price of S$0.02 — trading 60% below its estimated fair value. The current Cash-to-Debt is 0.40, which is 61% below median its 10-year median of 1.03 and 66.1% below the Industrial Products industry median of 1.18. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash-to-Debt calculated?
Cash-to-Debt is calculated from a company's financial statements. For HGH Holdings (SGX:5GZ), the current Cash-to-Debt is 0.40 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
HGH Holdings Ltd, through its subsidiaries, is engaged in the supply and manufacturing of ready-mix concrete products; supply of precast concrete products; providing one-stop high value-added general warehousing and logistics services, industrial, office space for engineering, manufacturing, industrial training, and workers' dormitory facilities; and providing underground cable installation and road reinstatement services. Its segments include leasing and service income, the Manufacturing of Precast Concrete products, the Supply and Manufacturing of Ready-Mix Concrete products; and the provision of Underground Cable Installation and Road Reinstatement.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SGX:5GZ has been successfully added to your 